Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Patients who took semaglutide for only four weeks experienced an impressive 2% reduction in body weight, and this weight loss continued throughout the study
Special considerations for specific populations Switching with type 2 diabetes If you are using semaglutide for both diabetes management and weight loss, the switch to tirzepatide requires extra monitoring
Though this advantage is narrowing as oral GLP-1 formulations become available, including the GLP-1 six-in-one oral liquid and various tablet formulations like tirzepatide tablets , injection aversion remains a real barrier for many patients
Battery capacity: 6,200mAh
Food and Drug Administration approved Wegovy (the first GLP-1 medicine aimed at weight loss) in mid-2021, sales of the drug and related GLP-1 meds such as Ozempic, Mounjaro and Zepbound have soared
